Navidea Biopharmaceuticals (NAVB) Raised at JMP Securities

Navidea Biopharmaceuticals Inc (NAVB) is one of today’s premarket biggest movers, up more than 7% to $1.34. The move may be attributed to analysts at JMP Securities, who upgraded Navidea’s shares to a ‘Market Outperform’ and raised its price target to $5.00 from $3.00 in a research note to investors on Thursday. JMP ’s new […] View the full post at: Navidea Biopharmaceuticals (NAVB) Raised at JMP Securities No related posts.